Literature DB >> 23786538

Ammonia clearance with haemofiltration in adults with liver disease.

Andrew J Slack1, Georg Auzinger, Chris Willars, Tracy Dew, Rebecca Musto, Daniel Corsilli, Roy Sherwood, Julia A Wendon, William Bernal.   

Abstract

BACKGROUND & AIMS: Ammonia is recognized as a toxin central to complications of liver failure. Hyperammonaemia has important clinical consequences, but optimal means to reduce circulating levels are uncertain. In patients with liver disease, continuous renal replacement therapy (CRRT) with haemofiltration (HF) is often required to treat concurrent kidney injury, but its effects upon ammonia levels are poorly characterized. To evaluate the effect of HF at different treatment intensities on ammonia clearance (AC) and arterial ammonia concentration.
METHODS: Prospective study of adult patients with liver failure and arterial ammonia >100 μmol/L requiring CRRT using veno-venous HF. Arterial ammonia concentration and AC measured at 1 and 24 h after initiation of low (35 ml/kg/h) or high (90 ml/kg/h) filtration volume.
RESULTS: Twenty-four patients (10 acute liver failure, 10 chronic liver disease and 4 following liver resection) were studied. Clearance of urea and ammonia solutes correlated closely (r = 0.819, P = 0.007). Ammonia clearance correlated closely with ultrafiltration rate (r = 0.86, P < 0.001). At 1 h, AC was 39 (34-54) ml/min (low volume) vs 85 (62-105) ml/min (high volume) CRRT, (P < 0.001) and at 24 h 44 (34-63) vs 105 (82-109) ml/min, (P = 0.01). Overall, a 22% reduction in median arterial ammonia concentration was observed over 24 h of HF from 156 (137-176) to 122 (85-133) μmol/L, (P ≤ 0.0001).
CONCLUSION: Clinically significant ammonia clearance can be achieved in adult patients with hyperammonaemia utilizing continuous VVHF. Ammonia clearance is closely correlated with ultrafiltration rate. HF was associated with a fall in arterial ammonia concentration.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Cordoba equation; ammonia clearance; haemofiltration; hyperammonaemia; ultrafiltration rate

Mesh:

Substances:

Year:  2013        PMID: 23786538     DOI: 10.1111/liv.12221

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  26 in total

Review 1.  Continuous Renal Replacement Therapy: Who, When, Why, and How.

Authors:  Srijan Tandukar; Paul M Palevsky
Journal:  Chest       Date:  2018-09-25       Impact factor: 9.410

2.  On the Brink of Death: Managing Acute Liver Failure.

Authors:  Rahul Maheshwari; Ram M Subramanian
Journal:  Am J Gastroenterol       Date:  2016-12-13       Impact factor: 10.864

Review 3.  Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.

Authors:  Rinaldo Bellomo; Claudio Ronco; Ravindra L Mehta; Pierre Asfar; Julie Boisramé-Helms; Michael Darmon; Jean-Luc Diehl; Jacques Duranteau; Eric A J Hoste; Joannes-Boyau Olivier; Matthieu Legrand; Nicolas Lerolle; Manu L N G Malbrain; Johan Mårtensson; Heleen M Oudemans-van Straaten; Jean-Jacques Parienti; Didier Payen; Sophie Perinel; Esther Peters; Peter Pickkers; Eric Rondeau; Miet Schetz; Christophe Vinsonneau; Julia Wendon; Ling Zhang; Pierre-François Laterre
Journal:  Ann Intensive Care       Date:  2017-05-04       Impact factor: 6.925

Review 4.  Management of acute-on-chronic liver failure: an algorithmic approach.

Authors:  Shiv Kumar Sarin; Ashok Choudhury
Journal:  Hepatol Int       Date:  2018-08-16       Impact factor: 6.047

5.  Successful Treatment of Severe Hyperammonaemia with Ultra-High Dose Continuous Veno-Venous Haemodiafiltration.

Authors:  Dirk P Boer; Sarah L Mourik; Martijn W F van den Hoogen; Janneke G Langendonk; Hilde R H de Geus
Journal:  Blood Purif       Date:  2019-05-03       Impact factor: 2.614

6.  Acute liver failure.

Authors:  Mohammed A Arshad; Nicholas Murphy; Mansoor N Bangash
Journal:  Clin Med (Lond)       Date:  2020-09       Impact factor: 2.659

7.  Management of hepatic encephalopathy.

Authors:  Jennifer A Frontera
Journal:  Curr Treat Options Neurol       Date:  2014-06       Impact factor: 3.598

Review 8.  The Role of RRT in Hyperammonemic Patients.

Authors:  Shruti Gupta; Andrew Z Fenves; Robert Hootkins
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

9.  Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure.

Authors:  Filipe S Cardoso; Michelle Gottfried; Shannan Tujios; Jody C Olson; Constantine J Karvellas
Journal:  Hepatology       Date:  2017-12-26       Impact factor: 17.425

10.  How to manage: acute liver failure.

Authors:  Oliver D Tavabie; William Bernal
Journal:  Frontline Gastroenterol       Date:  2019-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.